Study details
Enrolling now
A Clinical Trial to Evaluate Computer-Assisted Vacuum Thrombectomy for Cancer Patients with Intermediate Risk Pulmonary Embolism
M.D. Anderson Cancer Center
NCT IDNCT07298096ClinicalTrials.gov data as of Apr 2026
Target enrollment
25
Study length
about 5 months
Ages
18+
Locations
1 site in TX
About this study
Researchers are testing the safety and quality of life benefits of computer-assisted vacuum thrombectomy in cancer patients who have intermediate risk pulmonary embolism. The trial will also assess the safety of this procedure.
Based on ClinicalTrials.gov records.
What participants do
- 1.Undergo Aspiration Thrombectomy
Primary goalSafety and Adverse Events (AEs)
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low13%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Primary: Safety and Adverse Events (AEs)
Procedures
biopsy
Body systems
Oncology